Identification |
Name: | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt(1:1), (2S,3S,5R)- |
Synonyms: | 4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodiumsalt, (2S,3S,5R)- (9CI);4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, sodium salt,[2S-(2a,3b,5a)]-;CL 307579;Tazobactam sodium;YTR 830; |
CAS: | 89785-84-2 |
Molecular Formula: | C10H12N4O5S . Na |
Molecular Weight: | 322.27291 |
InChI: | InChI=1S/C10H12N4O5S.Na/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19;/h2-3,7-8H,4-5H2,1H3,(H,16,17);/q;+1/p-1/t7?,8-,10-;/m0./s1 |
Molecular Structure: |
|
Properties |
Density: | 1.92 g/cm3 |
Water Solubility: | H2O: 50 mg/mL, clear, colorless |
Solubility: | H2O: 50 mg/mL, clear, colorless |
Specification: | White to off-white powder usageEng:?Lactamase inhibitor, used with ?lactam antibiotics to enhance their effect Safety Statements:22-24/25-36-26 22:Do not breathe dust 24/25:Avoid contact with skin and eyes 36:Wear suitable protective clothing 26:In case of contact with eyes, rinse immediately with plenty
of water and seek medical advice |
Report: | Tazobactam sodium is reported in EPA TSCA Inventory. Glycol ether compounds are on the Community Right-To-Know List.
Safety Profile
Hazard Codes:? Xi
Risk Statements:? 36/37/38
Safety Statements:? 22-24/25-36-26
WGK Germany:? 3
RTECS:? XI0191500
?
|
Usage: | ?Lactamase inhibitor, used with ?lactam antibiotics to enhance their effect |
Safety Data |
|
|